Hiyama Toru, Tanaka Shinji, Haruma Ken, Chayama Kazuaki
Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University.
Nihon Rinsho. 2003 Jan;61(1):46-9.
To elucidate the significance of K-ras gene mutations in gastric carcinogenesis, we examined the mutations in gastric cancers and in Helicobacter pylori-associated chronic gastritis(H. pylori-CG). In gastric cancers, K-ras gene mutations were detected in intestinal type cancers, but not in diffuse type cancers. K-ras gene mutations in H. pylori-CG were significantly more frequent in gastric cancer patients than in cancer-free patients. These data suggest that K-ras gene mutations may be involved in the early stages of gastric carcinogenesis of the intestinal type. Recently, Uemura, et al. reported that H. pylori eradication suppressed gastric cancer development(Cancer Epidemiol Biomarkers Prev, 1997; N Engl J Med, 2001). Further examination is necessary to clarify the mechanism of suppression of gastric cancer development after H. pylori eradication.
为阐明K-ras基因突变在胃癌发生中的意义,我们检测了胃癌及幽门螺杆菌相关性慢性胃炎(H. pylori-CG)中的K-ras基因突变。在胃癌中,肠型癌可检测到K-ras基因突变,而弥漫型癌则未检测到。与未患癌症的患者相比,胃癌患者的H. pylori-CG中K-ras基因突变更为常见。这些数据表明,K-ras基因突变可能参与肠型胃癌发生的早期阶段。最近,上村等人报道,根除幽门螺杆菌可抑制胃癌发展(《癌症流行病学、生物标记与预防》,1997年;《新英格兰医学杂志》,2001年)。有必要进一步研究以阐明根除幽门螺杆菌后抑制胃癌发展的机制。